CANNTRUST HOLDINGS INC Inactive Instrument
CannTrust Holdings Inc Stock Canadian Securities Exchange
Equities
TRST
CA1378002077
Pharmaceuticals
| Sales 2017 | 20.7 28.36 | Sales 2018 | 45.65 62.55 | Capitalization | 508M 696M |
|---|---|---|---|---|---|
| Net income 2017 | 6M 8.22M | Net income 2018 | -13M -17.82M | EV / Sales 2017 | 31,215,427 x |
| Net cash position 2017 | 17.16M 23.52M | Net cash position 2018 | 58M 79.48M | EV / Sales 2018 | 9,864,003 x |
| P/E ratio 2017 |
81.5
x | P/E ratio 2018 |
-34.5
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
David Blair
DFI | Director of Finance/CFO | - | 19-09-30 |
| Sales & Marketing | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
Dan Hogan
BRD | Director/Board Member | - | 21-03-16 |
CannTrust Holdings Inc. is a holding company. The Companyâs primary asset is comprised of an approximately 10% equity interest in Phoena Holdings Inc. (Phoena). Phoena is a licensed cannabis producer, with locations in Vaughan and Fenwick, Ontario. Phoena operates a portfolio of brands, including estora, Liiv, SYNR.G and Xscape. It has four brands in the medical and recreational spaces. It offers a variety of dried flowers, pre-rolls, cannabis oils, capsules, topical gels and sublingual strips.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +38.08% | 6.01B | |
| -16.43% | 4.47B | |
| -12.46% | 3.11B | |
| -0.21% | 3.01B | |
| -0.59% | 2.6B | |
| +34.54% | 1.85B | |
| +0.93% | 1.66B | |
| -10.63% | 1.63B | |
| -12.50% | 1.53B |
